About Index Trending news
Analyze
Top 50 Pricing
Cerulean Pharma, Inc

Cerulean Pharma, Inc

Work at Cerulean Pharma, Inc? Add yourself to this profile

Cerulean Pharma, Inc

Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.

Elsewhere

Alexa global traffic share

07 Apr 2015
$35,000,000
Post-IPO equity
09 Jan 2015
$26,000,000
Debt financing
15 Dec 2011
$15,000,000
Venture capital (Series D)
15 Nov 2010
$24,000,000
Venture capital (Series C)
03 Jan 2008
$8,100,000
Venture capital (Series B)
23 May 2007
$12,100,000
Venture capital (Series A)
01 Dec 2006
$2,000,000
Venture capital